STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-05-03
Here’s whether Revolution Medicines, Inc. Common Stock (RVMD) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+8.26% over 10 days); RSI 52 — healthy momentum range; strong 1-year return of +243.2%; 3-month momentum positive (+43.6%). Currently 10.4% off its 52-week high. Score: +7/7.
RVMD is in a confirmed uptrend, trading above both its 50-day ($111.61) and 200-day ($76.33) moving averages. An RSI of 52.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +243.2% compares to +24.4% for SPY (beat the market by 218.8%).
$10,000 invested 1 year ago→ $34,321 today
vs. S&P 500 (SPY) — same period beat market by 218.8%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($76.33)
✓Above 50-day MA ($111.61)
✓RSI(14) neutral zone (30–70) — currently 52.3
✓Positive return (+243.2%)
!Within 10% of period high (−10.4%)
Period Range $139.48
$34.00$155.70
RSI (14) 52.3
0 · OversoldOverbought · 100
Key Metrics
Price$139.48
Period Return+243.2%
Period High$155.70
Period Low$34.00
Drawdown−10.4%
MA-50$111.61
MA-200$76.33
RSI (14)52.3
Avg Volume (30d)3.6M
vs. SPYbeat by 214.2%
Return Rank#76 of 1245
Trend Signals
Price is above the 200-day moving average ($76.33)
Price is above the 50-day moving average ($111.61)